After receiving FDA approval in April, Prolensa is now available for the treatment of inflammation and pain following cataract surgery.
There are already several non-steroidal anti-inflammatory (NSAID) eye drops out there for use after cataract surgery, including generics diclofenac sodium (Voltaren) and bromfenac, and brand name Bromday. Bromfenac and Bromday have the same active ingredient as Prolensa, but are slightly stronger (0.09% rather than 0.07% solutions).
Because there are several treatment options available, it may be worth discussing the best choice for you with your doctor. Prolensa may have other benefits over the existing NSAID eye drops, but with generics available in the same class, it’s less likely to be covered by insurance except under your highest copay. Coupons available start at around $190 for both the 3 ml and the 1.6 ml bottle.
In contrast, diclofenac sodium drops start at around $10 per bottle on some pharmacy discount generic programs, and are likely to be covered as a Tier 1 (or lowest-copay) generic on most insurance plans. Bromfenac drops are also likely to be covered under Tier 1 by most insurance plans, though the cost per bottle may be more like $60 – $150 depending on size and where you choose to fill.